Njeim R - Search Results

1

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.

Houeiss P, Njeim R, Tamim H, Hamdy AF, Azar TS, Azar WS, Noureldein M, Zeidan YH, Rashid A, Azar ST, Eid AA. Houeiss P, et al. Among authors: njeim r. J Adv Res. 2023 Feb;44:109-117. doi: 10.1016/j.jare.2022.04.013. Epub 2022 Apr 28. J Adv Res. 2023. PMID: 36725183 Free PMC article.

2

Novel triazine-based pyrimidines suppress glomerular mesangial cells proliferation and matrix protein accumulation through a ROS-dependent mechanism in the diabetic milieu.

Diab El-Harakeh M, Njeim R, Youssef A, Youssef N, Eid AA, Bouhadir KH. Diab El-Harakeh M, et al. Among authors: njeim r. Bioorg Med Chem Lett. 2019 Jul 1;29(13):1580-1585. doi: 10.1016/j.bmcl.2019.04.052. Epub 2019 May 2. Bioorg Med Chem Lett. 2019. PMID: 31078409

3

Role of the Nox4/AMPK/mTOR signaling axe in adipose inflammation-induced kidney injury.

Njeim R, Farhat T, Alkhansa S, Youssef N, Dia B, Slika R, Diab R, Azar ST, Eid AA. Njeim R, et al. Clin Sci (Lond). 2020 Feb 28;134(4):403-417. doi: 10.1042/CS20190584. Clin Sci (Lond). 2020. PMID: 32095833 Review.

4

COVID-19 and diabetes mellitus: how one pandemic worsens the other.

Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, Eid AA. Azar WS, et al. Among authors: njeim r. Rev Endocr Metab Disord. 2020 Dec;21(4):451-463. doi: 10.1007/s11154-020-09573-6. Rev Endocr Metab Disord. 2020. PMID: 32743793 Free PMC article. Review.

5

NETosis contributes to the pathogenesis of diabetes and its complications.

Njeim R, Azar WS, Fares AH, Azar ST, Kfoury Kassouf H, Eid AA. Njeim R, et al. J Mol Endocrinol. 2020 Nov;65(4):R65-R76. doi: 10.1530/JME-20-0128. J Mol Endocrinol. 2020. PMID: 33048064 Review.

6

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases.

Youssef N, Noureldein M, Njeim R, Ghadieh HE, Harb F, Azar ST, Fares N, Eid AA. Youssef N, et al. Among authors: njeim r. Biomedicines. 2021 Sep 30;9(10):1360. doi: 10.3390/biomedicines9101360. Biomedicines. 2021. PMID: 34680477 Free PMC article.

7

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.

Khurana I, Kaipananickal H, Maxwell S, Birkelund S, Syreeni A, Forsblom C, Okabe J, Ziemann M, Kaspi A, Rafehi H, Jørgensen A, Al-Hasani K, Thomas MC, Jiang G, Luk AO, Lee HM, Huang Y, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Fogarty C, Njeim R, Eid A, Hansen TW, Tofte N, Ottesen EC, Ma RC, Chan JC, Cooper ME, Rossing P, Groop PH, El-Osta A. Khurana I, et al. Among authors: njeim r. J Clin Invest. 2023 Feb 15;133(4):e160959. doi: 10.1172/JCI160959. J Clin Invest. 2023. PMID: 36633903 Free PMC article.

8

VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney Disease.

Njeim R, Braych K, Ghadieh HE, Azar NS, Azar WS, Dia B, Leone A, Cappello F, Kfoury H, Harb F, Jurjus AR, Eid AA, Ziyadeh FN. Njeim R, et al. Diabetes. 2023 Jul 1;72(7):947-957. doi: 10.2337/db22-0636. Diabetes. 2023. PMID: 36662655

9

SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism.

Dia B, Alkhansa S, Njeim R, Al Moussawi S, Farhat T, Haddad A, Riachi ME, Nawfal R, Azar WS, Eid AA. Dia B, et al. Among authors: njeim r. Pharmaceutics. 2023 Mar 16;15(3):965. doi: 10.3390/pharmaceutics15030965. Pharmaceutics. 2023. PMID: 36986825 Free PMC article.

10

Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease.

Njeim R, Alkhansa S, Fornoni A. Njeim R, et al. Pharmaceutics. 2023 Apr 28;15(5):1360. doi: 10.3390/pharmaceutics15051360. Pharmaceutics. 2023. PMID: 37242602 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page